TY - JOUR
T1 - Urinary 5-HIAA excretion is not increased in patients with head and neck paragangliomas
AU - van Hulsteijn, Leonie T.
AU - van Duinen, Nicolette
AU - Romijn, Johannes A.
AU - Smit, Johannes W.A.
AU - Corssmit, Eleonora P.M.
PY - 2012/4
Y1 - 2012/4
N2 - Background: Case reports have documented carcinoid-like features in head and neck paragangliomas (HNPGLs), which, in addition to catecholamine storing granules, may also contain granules with serotonin. Serotonin is metabolized to 5-hydroxyindoleacetic acid (5-HIAA). Aim: To assess the urinary excretion rates of 5-HIAA and catecholamines in HNPGL patients. Methods: In 114 consecutive HNPGL patients, normetanephrine, metanephrine, norepinephrine, epinephrine, VMA, dopamine, 3-methoxytyramine and 5-HIAA excretion rates were measured in two 24-hour urinary samples. Increased excretion rates were defined as an increase of the average hormone excretion rate of 2 urine samples above the reference range. In all patients with catecholamine excess, intrathoracic and abdominal paragangliomas were excluded by 123I-MIBG scintigraphy, MRI and/or CT. Genetic screening for mutations in genes of the succinate dehydrogenase (SDH) family was performed. Results: Mean urinary 5-HIAA excretion rate was 14±9 μmol/24 hours (reference range 10-44 μmol/24 hours). Urinary 5-HIAA excretion was slightly increased in only 1 patient (48 μmol/24 hours). None of the 50 patients (44%) with increased urinary excretion rates of catecholamines and/or their metabolites had elevated 5-HIAA excretion. Conclusion: Urinary 5-HIAA excretion is within the normal reference range in almost all HNPGL patients. Therefore, this parameter has no clinical relevance in the routine clinical assessment of HNPGL patients.
AB - Background: Case reports have documented carcinoid-like features in head and neck paragangliomas (HNPGLs), which, in addition to catecholamine storing granules, may also contain granules with serotonin. Serotonin is metabolized to 5-hydroxyindoleacetic acid (5-HIAA). Aim: To assess the urinary excretion rates of 5-HIAA and catecholamines in HNPGL patients. Methods: In 114 consecutive HNPGL patients, normetanephrine, metanephrine, norepinephrine, epinephrine, VMA, dopamine, 3-methoxytyramine and 5-HIAA excretion rates were measured in two 24-hour urinary samples. Increased excretion rates were defined as an increase of the average hormone excretion rate of 2 urine samples above the reference range. In all patients with catecholamine excess, intrathoracic and abdominal paragangliomas were excluded by 123I-MIBG scintigraphy, MRI and/or CT. Genetic screening for mutations in genes of the succinate dehydrogenase (SDH) family was performed. Results: Mean urinary 5-HIAA excretion rate was 14±9 μmol/24 hours (reference range 10-44 μmol/24 hours). Urinary 5-HIAA excretion was slightly increased in only 1 patient (48 μmol/24 hours). None of the 50 patients (44%) with increased urinary excretion rates of catecholamines and/or their metabolites had elevated 5-HIAA excretion. Conclusion: Urinary 5-HIAA excretion is within the normal reference range in almost all HNPGL patients. Therefore, this parameter has no clinical relevance in the routine clinical assessment of HNPGL patients.
KW - 5-HIAA
KW - Catecholamines
KW - Head and neck paraganglioma
KW - Serotonin
UR - http://www.scopus.com/inward/record.url?scp=84871036957&partnerID=8YFLogxK
U2 - 10.5301/JBM.2012.9312
DO - 10.5301/JBM.2012.9312
M3 - Article
C2 - 22653742
AN - SCOPUS:84871036957
SN - 0393-6155
VL - 27
SP - 160
EP - 163
JO - International Journal of Biological Markers
JF - International Journal of Biological Markers
IS - 2
ER -